- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05640921
Group-integrated Cognitive Behavioural Therapy (Gi-CBT) to Aid Communities' Reintegration of Former Terrorists in Nigeria: A Randomised Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The main question it aims to answer are:
• What is the feasibility in terms of recruitment, retention, adherence to the intervention and communities/victims' satisfaction with Gi-CBT to promote healing and improve the successful reintegration of of former Boko Haram terrorists' members and their families.into society?
Participants will be randomly allocated into two groups. The first group, the intervention group, will receive the Group integrated Cognitive Behavioural Therapy (Gi-CBT). The second group will receive government intervention involving media messages from the National Orientation Agency devoid of GiCBT.
Researchers will compare Gi-CBT group with the media orientation group to see if there are differences between a change in attitude towards ex-offenders' reintegration at base line, end of intervention and three months follow up.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- community members who had previous experience of trauma as a result of Boko Haram atrocities, score 5 and above for the culturally-adapted Trauma Screening Questionnaire (Brewinn et al., 2002)
- are aged 18+ years and above
- are residents of the designated areas including Bornu (Maiduguri), and its environs.
Exclusion Criteria:
- those not meeting the study inclusion criteria will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group-integrated Cognitive Behavioural Therapy (Gi-CBT)
The Gi-CBT sessions will cover relevant aspects of tackling trauma, and the CBT component will involve addressing negative thoughts, building more positive ones and building resilience through post-traumatic situations and adversities.
|
Gi-CBT designed to cover relevant aspects of tackling trauma, and the CBT component will involve addressing negative thoughts, building more positive ones and building resilience.
|
|
Active Comparator: Media Intervention
The second group will receive Media Orientation (MO).
The MO sessions will embed media content to create awareness of the government's approaches to reintegration.
|
The MO sessions will embed media content to create awareness of the government's approaches to reintegration.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Service Satisfaction Scale
Time Frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]
|
Change in service satisfaction is being assessed
|
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]
|
|
PHQ-9
Time Frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]
|
Change in Depressive Symptoms
|
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]
|
|
The Attitude Towards Repentant Terrorist and their Reintegration scale
Time Frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]
|
Change in attitude towards reintegration
|
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]
|
|
Trauma Screening Questionnaire
Time Frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention
|
Change in traumatic experience is being assessed
|
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0000-0003-0516-0313c
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on Gi-CBT
-
Maastricht University Medical CenterCompleted
-
NestléClinical Nutrition Research Centre, SingaporeCompleted
-
Temple UniversityInternational Life Sciences InstituteCompleted
-
Ohio State UniversityCompletedGlucose Metabolism Disorders | Spinal Cord Injuries | Postprandial HypotensionUnited States
-
Federal University of VicosaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...CompletedType 2 Diabetes MellitusBrazil
-
GI DynamicsCompleted
-
Radicle ScienceCompleted
-
Kirstine Nyvold Bojsen-MoellerUniversity of CopenhagenCompleted
-
Radicle ScienceRecruitingGI Health | Belly PainUnited States
-
Maastricht University Medical CenterUnilever R&DCompletedObesity | Diet, Healthy | Fatty Liver, NonalcoholicNetherlands